To validate the clinical significance of Rab3B in lung cancer, immunohistochemistry for Rab3B was performed in paired tumor and adjacent normal tissues from a cohort of 92 lung adenocarcinoma patients. This evidence concerns the gene RAB3B and lung adenocarcinoma.